Munafa Stock Market Course + Intraday & FNO calls 
Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Outlook Therapeutics (OTLK)
Technical Analysis Report for USA stock OTLK Outlook Therapeutics. Dated: 26 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock OTLK Outlook Therapeutics then click here. or read Experts views on Outlook Therapeutics or Forecast & share price targets of Outlook Therapeutics
Outlook Therapeutics Opened at 0.51 and Closed at: 0.51, which is -1.96% of previous session's close. It moved within a range of 0.49 and 0.53
The session was a Neutral session with an average volume of 2412615, which is -27.78% of previous session's volumes.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
Support for tomorrow is 0.49 and resistance for tomorrow is 0.53
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.49, 0.47 resistance for tomorrow's hourly charts is 0.53, 0.55
10 Day SMA for Outlook Therapeutics (OTLK) is 0.52 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Outlook Therapeutics (OTLK) is 0.55 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Outlook Therapeutics (OTLK) is 0.61 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.96 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Outlook Therapeutics is 0.67 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Outlook Therapeutics is at 0.55 and 200 DMA is at 0.67, while 50 DMA and 100 DMA are at 0.61 and 0.96 respectively
Outlook Therapeutics (OTLK) moving average of 20 SMA is at 0.55 and 20 EMA is at 0.56
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Mon Oct | 0.51 | 0.55 | 0.56 |
| 23 Fri Oct | 0.52 | 0.56 | 0.57 |
| 22 Thu Oct | 0.56 | 0.57 | 0.57 |
| 21 Wed Oct | 0.57 | 0.57 | 0.57 |
| 20 Tue Oct | 0.52 | 0.58 | 0.57 |
| 19 Mon Oct | 0.51 | 0.59 | 0.58 |
Outlook Therapeutics (OTLK) moving average of 50 SMA is at 0.61 and 50 EMA is at 0.63
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Mon Oct | 0.51 | 0.61 | 0.63 |
| 23 Fri Oct | 0.52 | 0.62 | 0.64 |
| 22 Thu Oct | 0.56 | 0.63 | 0.64 |
| 21 Wed Oct | 0.57 | 0.64 | 0.64 |
| 20 Tue Oct | 0.52 | 0.65 | 0.64 |
| 19 Mon Oct | 0.51 | 0.66 | 0.65 |
Outlook Therapeutics (OTLK) moving average of 100 SMA is at 0.96 and 100 EMA is at 0.76
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Mon Oct | 0.51 | 0.96 | 0.76 |
| 23 Fri Oct | 0.52 | 0.96 | 0.77 |
| 22 Thu Oct | 0.56 | 0.96 | 0.77 |
| 21 Wed Oct | 0.57 | 0.97 | 0.77 |
| 20 Tue Oct | 0.52 | 0.97 | 0.77 |
| 19 Mon Oct | 0.51 | 0.97 | 0.77 |
Outlook Therapeutics (OTLK) moving average of 200 SMA is at 0.67 and 200 EMA is at 0.94
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Mon Oct | 0.51 | 0.67 | 0.94 |
| 23 Fri Oct | 0.52 | 0.67 | 0.94 |
| 22 Thu Oct | 0.56 | 0.67 | 0.94 |
| 21 Wed Oct | 0.57 | 0.67 | 0.94 |
| 20 Tue Oct | 0.52 | 0.67 | 0.94 |
| 19 Mon Oct | 0.51 | 0.67 | 0.94 |
Inspire Medical has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Inspire Medical, about 16.08% more returns!
Glaxosmithkline Plc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 22.6% more returns!
Charles River has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Charles River, about 39.77% more returns!
Cardinal Health has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Cardinal Health, about 31.39% more returns!
Becton Dickinson has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Becton Dickinson, about 26.97% more returns!
Vertex Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 17.3% more returns!
Veracyte Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Veracyte Inc, about 23.65% more returns!
Rocket Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Rocket Pharmaceuticals, about 7.08% more returns!
Phio Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 1.57% more returns!
Omeros Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Omeros Corporation, about 3.67% more returns!
Intellia Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 12.65% more returns!
Atyr Pharma has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Atyr Pharma, about 44.01% more returns!
Kamada has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Kamada, about 10.31% more returns!
Outlook Therapeutics has performed better than Insmed Inc in short term. Holding Outlook Therapeutics could be a better choice for now!
Henry Schein has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Henry Schein, about 18.51% more returns!
Dexcom Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Dexcom Inc, about 9.74% more returns!
Dbv Technologies has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Dbv Technologies, about 5.46% more returns!
Outlook Therapeutics Technical analysis of indicators
Price action analysis of Outlook Therapeutics (OTLK) based on a short term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
Outlook Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.51 and Outlook Therapeutics OTLK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics OTLK stock. Volume based technical analysis of Outlook Therapeutics OTLK stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock OTLK Outlook Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And OTLK Experts View which covers a lot of information including buying and selling signals
OTLK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Outlook Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
